ketotifen has been researched along with Symptom Cluster in 2 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asawa, A | 1 |
Simpson, KH | 1 |
Bonds, RS | 1 |
Yamanaka, K | 1 |
Kuwashima, K | 1 |
2 other studies available for ketotifen and Symptom Cluster
Article | Year |
---|---|
Ketotifen use in a patient with fire ant hypersensitivity and mast cell activation syndrome.
Topics: Adult; Anaphylaxis; Animals; Ant Venoms; Anti-Allergic Agents; Ants; Asthma; Erythema; Female; Hista | 2015 |
[Effect of ketotifen fumarate for seizures in Lennox-Gastaut syndrome; a care report].
Topics: Administration, Oral; Anti-Allergic Agents; Child; Dermatitis, Atopic; Epilepsy, Absence; Humans; Ke | 1999 |